Spectrum Pharma Inc (SPPI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2014 | 03-2014 | 12-2013 | 09-2013 | 06-2013 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -31,204 | -27,641 | -62,134 | -22,762 | -15,157 |
| Depreciation Amortization | 14,819 | 7,258 | 9,840 | 4,949 | 472 |
| Income taxes - deferred | 72 | -2 | 33,252 | -10,016 | -6,039 |
| Accounts receivable | -11,494 | -5,101 | 42,686 | 37,246 | 39,790 |
| Other Working Capital | -23,639 | -30,255 | 7,672 | 10,130 | 19,689 |
| Other Operating Activity | 27,116 | 15,752 | -33,402 | -29,553 | -35,311 |
| Operating Cash Flow | $-24,330 | $-39,989 | $-2,086 | $-10,006 | $3,444 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -605 | -320 | -161 | -127 | -127 |
| Net Acquisitions | N/A | N/A | -14,169 | -11,189 | -3,000 |
| Sale Of Investment | 165 | N/A | N/A | N/A | N/A |
| Purchase Sale Intangibles | N/A | N/A | N/A | -3,000 | N/A |
| Other Investing Activity | 0 | 0 | 0 | -3,000 | 0 |
| Investing Cash Flow | $-440 | $-320 | $-14,330 | $-14,316 | $-3,127 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | N/A | N/A | 7,000 | 7,000 | N/A |
| Debt Issued | N/A | N/A | 220,000 | 100,000 | 100,000 |
| Debt Repayment | N/A | N/A | -175,000 | -150,000 | -125,000 |
| Common Stock Issued | 1,687 | 1,241 | 15,174 | 3,167 | 1,334 |
| Common Stock Repurchased | -590 | N/A | -27,343 | -2,264 | -2,062 |
| Other Financing Activity | 0 | 0 | -4,573 | 0 | 7,000 |
| Financing Cash Flow | $1,097 | $1,241 | $35,258 | $-42,097 | $-18,728 |
| Exchange Rate Effect | -228 | 496 | -2,235 | -1,305 | -184 |
| Beginning Cash Position | 156,306 | 156,306 | 139,698 | 139,698 | 139,698 |
| End Cash Position | 132,405 | 117,734 | 156,306 | 71,974 | 121,103 |
| Net Cash Flow | $-23,901 | $-38,572 | $16,608 | $-67,724 | $-18,595 |
| Free Cash Flow | |||||
| Operating Cash Flow | -24,330 | -39,989 | -2,086 | -10,006 | 3,444 |
| Capital Expenditure | -605 | -320 | -161 | -127 | -127 |
| Free Cash Flow | -24,935 | -40,309 | -2,247 | -10,133 | 3,317 |